Kaoruko Shimizu Selected Research

Kaoruko Shimizu Research Topics

Disease

19	Asthma (Bronchial Asthma) 06/2022 - 06/2008
13	Chronic Obstructive Pulmonary Disease (COPD) 08/2021 - 10/2011
5	Inflammation (Inflammations) 01/2020 - 10/2011
2	Allergic Rhinitis 01/2021 - 07/2018
2	Tuberous Sclerosis (Bourneville's Disease) 01/2019 - 01/2018
2	Emphysema 01/2019 - 01/2012
2	Hyperplasia 01/2019 - 01/2018
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018 - 07/2014
2	Eosinophilia 12/2016 - 12/2010
2	Dyspnea (Shortness of Breath) 12/2014 - 10/2011
1	Overweight 06/2022
1	Respiratory Hypersensitivity 06/2022
1	Airway Remodeling 01/2022
1	Confusion (Bewilderment) 05/2021
1	Rhinosinusitis 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Clinical Deterioration 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Respiratory Sounds (Crackle) 10/2018
1	Eczema 10/2018
1	Obesity 07/2018
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018
1	Pleural Effusion (Pleural Effusions) 12/2014
1	Bronchiolitis 12/2010
1	Sarcoidosis (Schaumann Disease) 10/2010
1	Pulmonary Sarcoidosis 09/2010
1	Rhinitis 05/2010

Drug/Important Bio-Agent (IBA)

4	Bronchodilator Agents (Bronchodilators)IBA 01/2017 - 10/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 05/2014
3	Carbon MonoxideIBA 01/2021 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
3	Immunoglobulin E (IgE)IBA 12/2016 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2022
2	GoldIBA 05/2021 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2020
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 01/2018
2	AdipokinesIBA 07/2018 - 12/2014
2	Biological ProductsIBA 01/2018 - 12/2015
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2017 - 10/2016
2	AntigensIBA 12/2016 - 05/2010
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2016 - 05/2014
2	montelukast (Singulair)FDA Link 01/2016 - 05/2014
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2016 - 05/2014
2	Phenobarbital (Luminal)FDA Link 06/2015 - 01/2014
2	AntioxidantsIBA 07/2014 - 10/2011
2	arginylarginine (Arg-Arg)IBA 05/2014 - 06/2008
2	Prednisolone (Predate)FDA LinkGeneric 12/2010 - 09/2010
2	Mannose ReceptorIBA 10/2010 - 12/2009
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	ChitinasesIBA 01/2022
1	CalciumIBA 08/2021
1	mepolizumabIBA 01/2020
1	benralizumabIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	CotinineIBA 10/2018
1	PeriostinIBA 07/2018
1	lipoarabinomannan (LAM)IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2016
1	indacaterolIBA 10/2016
1	Thyroglobulin FDA Link 12/2014
1	AdiponectinIBA 12/2014
1	LeptinIBA 12/2014
1	CatalaseIBA 07/2014
1	UteroglobinIBA 11/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2013
1	Expectorants (Mucolytics)IBA 10/2011
1	C-Type Lectins (C-Type Lectin)IBA 10/2010
1	SteroidsIBA 06/2008

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2019 - 10/2011
1	Precision Medicine 10/2011
1	Aftercare (After-Treatment) 12/2010